ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.

ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer. Cell Biol Int. 2019 Sep 02.

View in: PubMed